About Krissy Wright
Krissy Wright is Endogenex’s chief financial officer. She leads financial strategy, corporate development, and operational planning for its clinical programs. Endogenex is testing an outpatient endoscopic procedure that applies nonthermal pulsed electric fields to the duodenum for type 2 diabetes. Wright joined in September 2024 and has 25 years of accounting and finance experience.
Before Endogenex, Wright was CFO at heart-diagnostics company Cleerly. At Medtronic, she led Brain Modulation and served as finance chief for the Neuromodulation Operating Unit. Earlier, she spent 11 years at PricewaterhouseCoopers in audit, assurance, and transaction services. She serves on Paragon28’s board. She earned an accounting bachelor’s degree from the University of Minnesota and an MBA from Duke University’s Fuqua School of Business.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Krissy Wright in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Krissy Wright works with at each company, as listed on that company's latest Form D.
